C17H17N3O6S
391.4 g/mol
Pharmaceutical IntermediateWarning
2,4-Bis((furan-2-ylmethyl)amino)-5-sulfamoylbenzoic acid
CAS5046-19-5
Category
Pharmaceutical Intermediate
Compound Class
Amine
Primary Use
Pharmaceutical Intermediate
This compound is a sulfamoylbenzoic acid derivative featuring two furan-2-ylmethylamino substituents. It is primarily utilized as a pharmaceutical intermediate in the research and manufacturing of active pharmaceutical ingredients.
Pharmaceutical intermediateResearch compound for drug development
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 5046-19-5
Related Compounds
SimilarStructure SimilarSimilarity 0.81
Furosemide
CAS54-31-9
pharmaceutical raw material
ReferenceSame Category
Aminopyrazine
CAS5049-61-6
pharmaceutical intermediate
ReferenceSame Category
Di-p-anisoyl-L-tartaric acid
CAS50583-51-2
pharmaceutical intermediate
ReferenceSame Category
2a,3a,16a,17a-Diepoxy-17b-acetoxy-5a-androstane
CAS50588-22-2
pharmaceutical intermediate
ReferenceSame Category
17-Acetoxy-5a-androsta-2,16-diene
CAS50588-42-6
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name
2,4-bis(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid
InChIKey
NQRLIXFNJZQNKV-UHFFFAOYSA-N
SMILES
C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)NCC3=CC=CO3
Synonyms (12)
- 2,4-Bis[(furan-2-ylmethyl)amino]-5-sulphamoylbenzoic Acid; Furosemide Imp. D (EP); Furosemide Impurity D
- FUROSEMIDE IMPURITY D (EP IMPURITY)
- Furosemide EP Impurity D
- FUROSEMIDE IMPURITY D